REFERENCES
- Dick J. Macular edema. Int Ophthalmol Clin. 1999; 39(4)1–18, [PUBMED], [INFOTRIEVE], [CSA]
- Lang G E. [Therapy of diabetic retinopathy with somatostatin analogs]. Ophthalmologe. 2004; 101(3)290–293, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kuijpers R, Baarsma G, van Hagen P. Treatment of cystoid macular edema with octreotide (Letter). N Engl J Med. 1998; 338(9)624–626, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rothova A. Medical treatment of cystoid macular edema. Ocul Immunol Inflamm. 2002; 10(4)239–246, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Grant M, Caballero S, Millard W. Inhibition of IGF-1 and b-FGF stimulated growth of human retinal endothelial cells by the somatostatin analogue octreotide: a potential treatment for ocular neovascularization. Regul Peptides. 1993; 48: 267–278, [CSA], [CROSSREF]
- van Hagen P M, Baarsma G S, Mooy C M, Ercoskan E M, ter Averst E, Hofland L J, Lamberts S W, Kuijpers R W. Somatostatin and somatostatin receptors in retinal diseases. Eur J Endocrinol. 2000; 143S: S43–S51, [CSA], [CROSSREF]
- van Hagen P M, Krenning E P, Kwekkeboom D J, Reubi J C, Anker-Lugtenburg P J, Lowenberg B, Lamberts S W. Somatostatin and the immune and hematopoetic system: a review. Eur J Clin Invest. 1994; 24: 91–99, [PUBMED], [INFOTRIEVE], [CSA]